Publications and Presentations

Cancer Biology and Therapeutics Research Program - Affiliated Publications

1. Gad S, Ye R, Qiu W. In vivo CRISPR Activation Screening, a Powerful Tool to Discover Oncogenic Driver Genes in Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2025;19(5):101459. doi: 10.1016/j.jcmgh.2024.101459. Epub 2025 Jan 21. PMID: 39855631; PMCID: PMC12009093
2. Wang F, Keating CR, Xu Y, Hou W, Malnassy G, Boedeker K, Perera A, Ham E, Patel D, Ding X, Qiu W. Suppression of Hepatocellular Carcinoma by Deletion of SIRT2 in Hepatocytes via Elevated C/EBPβ/GADD45γ. Cell Mol Gastroenterol Hepatol. 2025;19(7):101494. doi: 10.1016/j.jcmgh.2025.101494. Epub 2025 Mar 11. PMID: 40081570; PMCID: PMC12264431.
3. Zarei M, Hajihassani O, Hue JJ, Loftus AW, Graor HJ, Nakazzi F, Naji P, Boutros CS, Uppin V, Vaziri-Gohar A, Shalaby AS, Asara JM, Rothermel LD, Brody JR, Winter JM. IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer. Cancer Res. 2024 Sep 16;84(18):3072-3085. doi: 10.1158/0008-5472.CAN-23-1895. PMID: 38843355; PMCID: PMC11403292.
4. Young KS, Hancock GR, Fink EC, Zigrossi A, Flowers B, Cooper DA, Nguyen VT, Martinez MC, Mon KS, Bosland M, Zak DR, Runde AP, Sharifi MN, Kastrati I, Minh DDL, Kregel S, Fanning SW. Targeting unique ligand binding domain structural features downregulates DKK1 in Y537S ESR1 mutant breast cancer cells. Breast Cancer Res. 2025 Jan 17;27(1):10. doi: 10.1186/s13058-024-01945-z. PMID: 39825366; PMCID: PMC11742495.
5. Budreika A, Phoenix JT, Kostlan RJ, Deegan CD, Ferrari MG, Young KS, Fanning SW, Kregel S. The Homeobox Transcription Factor NKX3.1 Displays an Oncogenic Role in Castration-Resistant Prostate Cancer Cells. Cancers (Basel). 2025 Jan 18;17(2):306. doi: 10.3390/cancers17020306. PMID: 39858088; PMCID: PMC11763476.

Radiation Oncology Imaging and Technology Research Program - Affiliated Publications

1. Braunstein LZ, Mitchell MP, Bandos H, Sikov WM, Khan AJ, Chen PY, Ganz PA, Jagsi R, White JR, Cecchini RS, Kang H, Puhalla SL, Bolton KL, Connolly EP, Stringer-Reasor EM, Gergelis KR, Julian TB, Mamounas EP, Wolmark N. NRG- BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer. Future Oncol. 2025 Jul;21(16):2017-2025.doi: 10.1080/14796694.2025.2511586. Epub 2025 Jun 26. PMID: 40574381; PMCID:PMC12218515. 
2. Russo S, Anker CJ, Codipilly DC, Abood G, Akselrod D, Hallemeier CL, Jethwa KR, Jin Z, Kim E, Kennedy T, Lee P, Miller ED, Newman NB, Selfridge JE, Sharma N, Small W Jr, Tchelebi L, Williams VM, Simone CB 2nd. Executive Summary of the American Radium Society Appropriate Use Criteria for the Use of Esophageal Stents in Patients With Esophageal Cancer: Systematic Review and Guidelines. Am J Clin Oncol. 2025 Jun 25. doi: 10.1097/COC.0000000000001222. Epub ahead of print. PMID: 40557604. 
3. Chao ST, Berkowitz A, Harris EER, Henderson MA, Lo SS, Pacella M, Palmer J, Saeed H, Simone CB 2nd, Ziemer BP, Small W Jr, Schechter NR. ACR-ARS Practice Parameter for the Performance of Stereotactic Body Radiation Therapy. Am J Clin Oncol. 2025 Jun 23. doi: 10.1097/COC.0000000000001224. Epub ahead of print.PMID: 40548549. 
4. Garsa A, Buckey CR, Davis BJ, Freedman L, Gros SAA, Hallemeier CL, Lo SS, Milano MT, Saeed H, Ye JC, Small W Jr, Schechter NR. ACR-ARS Practice Parameter for Image-Guided Radiation Therapy (IGRT). Am J Clin Oncol. 2025 Jun 20. doi: 10.1097/COC.0000000000001220. Epub ahead of print. PMID: 40539501. 
5. Brower JV, Russo AL, Bradley KA, Fisher CM, Carlson R, Brubaker LW, Hagen PA, Leaf RK, Small W Jr, Klopp AH. Management of Venous Thrombosis and Pulmonary Embolism During Cervical Brachytherapy. Pract Radiat Oncol. 2025 Jun 14:S1879-8500(25)00119-5. doi: 10.1016/j.prro.2025.04.013. Epub ahead of print. PMID: 40523472. 
6. Pozin J, Bhandari M, Valle L, Nickols NG, Kishan AU, Kamran SC, Baumann B, Efstathiou JA, Crook J, Pasquier D, Liauw SL, Harkenrider MM, Solanki AA. The Evolving Management of Radiorecurrent Prostate Cancer. Semin Radiat Oncol. 2025 Jul;35(3):450-462. doi: 10.1016/j.semradonc.2025.04.014. PMID: 40516980. 
7. Klebaner D, Jagsi R, Barry PN, Bagshaw H, Masters AH, Gibbs IC, Small W Jr, Giuliano A, Nguyen KT, Baniel C. Deconstructing Barriers to 12 Weeks of Parental Leave for Birthing and Nonbirthing Parents in Radiation Oncology Residency Training. Pract Radiat Oncol. 2025 Jun 9:S1879-8500(25)00153-5. doi: 10.1016/j.prro.2025.05.009. Epub ahead of print. PMID: 40499813. 
8. Expert Panel on Cardiac Imaging; Meyersohn NM, Parakh A, Ghoshhajra BB, Agarwal PP, Bourque JM, Chamarthy MRK, De Cecco CN, Ehrhardt M, Fuss C, Kallianos K, Lopez-Mattei JC, Malik SB, Manisty C, Maroules CD, Ray A, Scherrer- Crosbie M, Small W Jr, Tailor TD, Koweek LM. ACR Appropriateness Criteria® Assessment of Cardiac Function and Baseline Cardiac Risk Stratification in Oncology Patients. J Am Coll Radiol. 2025 May;22(5S):S67-S78. doi: 10.1016/j.jacr.2025.02.038. PMID: 40409896. 
9. Expert Panel on Breast Imaging; Paulis LV, Lewin AA, Weinstein SP, Baron P, Dayaratna S, Dodelzon K, Dogan BE, Gulati A, Kantor O, Kasales C, Kunjummen JM, Kuzmiak CM, Newell MS, Salkowski LR, Sharpe RE Jr, Small W Jr, Ulaner GA, Slanetz PJ. ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density: 2024 Update. J Am Coll Radiol. 2025 May;22(5S):S405-S423. doi: 10.1016/j.jacr.2025.02.023. PMID: 40409891. 
10. Expert Panel on Gastrointestinal Imaging; Horvat N, Liu PS, Fowler KJ, Birkholz JH, Cash BD, Dane B, Eng C, Kambadakone AR, Korngold EK, Pietryga JA, Refaat T, Santillan CS, Surasi DS, Woolsey S, Kim DH. ACR Appropriateness Criteria® Staging and Follow-up of Anal Cancer. J Am Coll Radiol. 2025 May;22(5S):S396-S404. doi: 10.1016/j.jacr.2025.02.018. PMID: 40409890. 
11. Expert Panel on GYN and OB Imaging; Venkatesan AM, Kilcoyne A, Akin EA, Chuang L, Hindman NM, Huang C, McCourt CK, Rauch GM, Sattari M, Schoenborn N, Schultz D, Sertic M, Small W Jr, Stein EB, Suarez-Weiss K, Kang SK. ACR Appropriateness Criteria® Ovarian Cancer Screening: 2024 Update. J Am Coll Radiol. 2025 May;22(5S):S359-S371. doi: 10.1016/j.jacr.2025.02.016. PMID: 40409887. 
12. Koneru BN, Sick J, Shaikh HA, Spengler H, Small W Jr, Shaffer R. Low-Dose Radiation Therapy for Osteoarthritis: A Retrospective Single-Institution Analysis of 69 Patients and 168 Joints. Int J Radiat Oncol Biol Phys. 2025 May 9:S0360-3016(25)00439-0. doi: 10.1016/j.ijrobp.2025.04.040. Epub ahead of print. PMID: 40349853. 
13. Keeler A, Luce J, Lehmann M, Roeske JC, Kang H. Fast, automated optimization of virtual monoenergetic images with the dual-energy image synthesizer for cone- beam CT. J Appl Clin Med Phys. 2025 Jun;26(6):e70083. doi: 10.1002/acm2.70083. Epub 2025 Apr 22. PMID: 40260755; PMCID: PMC12148776. 
14. Jia X, Rong Y, Wu Q, Cardenas CE, Court LE, Hrinivich WT, Kang H, Kovalchuk N, Whitaker TJ, Xiao Y, Zhang P, Chen Q. NRG Oncology Assessment of Artificial Intelligence for Automatic Treatment Planning in Radiation Therapy Clinical Trials: Present and Future. Int J Radiat Oncol Biol Phys. 2025 Sep 1;123(1):282-295. doi: 10.1016/j.ijrobp.2025.03.045. Epub 2025 Mar 29. PMID: 40164355; PMCID: PMC12228557. 
15. Nguyen H, Lehmann M, Morf D, Luce J, Keeler A, Kang H, Roeske JC. Evaluation of novel detector readout modes for MV scatter reduction on kV images. Med Phys. 2025 Jun;52(6):4793-4803. doi: 10.1002/mp.17776. Epub 2025 Mar 27. PMID: 40146008. 
16. Peanlikhit T, Aryal U, Welsh JS, Shroyer KR, Rithidech KN. Evaluation of the Inhibitory Potential of Apigenin and Related Flavonoids on Various Proteins Associated with Human Diseases Using AutoDock. Int J Mol Sci. 2025 Mar 12;26(6):2548. doi: 10.3390/ijms26062548. PMID: 40141193; PMCID: PMC11942390. 
17. Thakkar JP, Luy DD, Pickles A, Refaat T, Prabhu VC. Chronic Neurological Complications of Brain Tumors and Brain Tumor Treatments. Curr Neurol Neurosci Rep. 2025 Mar 21;25(1):26. doi: 10.1007/s11910-025-01411-z. PMID: 40116979. 
18. Venkatesulu B, Adams W, Joel R, Ross D, Yoo R, Quick C, Baldea KG, Barkan G, Block A, Bova D, Farooq A, Garant A, Gupta G, Shea SM, Showalter TN, Small W, Welsh JS, Harkenrider MM, Solanki AA. The Importance of Multiparametric Magnetic Resonance Imaging, Positron Emission Tomography/Computed Tomography, and Biopsy for Identifying and Delineating the Extent of Intraprostatic Radiorecurrent Prostate Cancer: A Secondary Analysis of the F-SHARP Clinical Trial. Int J Radiat Oncol Biol Phys. 2025 Aug 1;122(5):1186-1191. doi: 10.1016/j.ijrobp.2025.02.042. Epub 2025 Mar 6. PMID: 40057285. 
19. Djukelic M, Martin CJ, Abuhaimed A, Kron T, Gros S, Wood T, Pankowski P, Ung NM, Vassileva J, Plazas MC, Vostinic S, Lazovic A, Sá AC, Nilsson I, Koutrouli M, Murugan L, Fourie H, Miadzvetski A, Ameri BA, Dumancic M, Cheung AH, Rahbi ZA, Roussakis Y, Shaaban HR, Liang R, Tomic N, Salazar Correa DE, Butler D, Small W Jr. Cone beam CT (CBCT) in radiotherapy: Assessment of doses using a pragmatic setup in an international setting. Phys Med. 2025 Mar;131:104937. doi: 10.1016/j.ejmp.2025.104937. Epub 2025 Feb 21. PMID: 39985958. 
20. Faraz M, Nematollahi S, Tahmasebi S, Welsh JS, Bevelacqua JJ, Mortazavi SMJ, Mortazavi SA. The Association between Breast Cup Size and Breast Cancer Incidence: Insights from a Global Dataset. J Biomed Phys Eng. 2025 Feb 1;15(1):93-100. doi: 10.31661/jbpe.v0i0.2412-1869. PMID: 39975528; PMCID: PMC11833153. 
21. Williams VM, Hallemeier CL, Jethwa KR, Selfridge JE, Shah P, Anker CJ, Abood G, Akselrod D, Berlin J, Kim E, Kennedy T, Lee P, Sharma N, William S Jr, Tchelebi L, Russo S; Expert Panel Management of Cervical Esophageal Cancer. Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus: Systematic Review and Guidelines. Am J Clin Oncol. 2025 Apr 1;48(4):163-179. doi: 10.1097/COC.0000000000001165. Epub 2025 Feb 6. PMID: 39912327. 
22. Clements A, Enserro D, Strickland KC, Previs R, Matei D, Mutch D, Powell M, Klopp A, Miller DS, Small W Jr, DiSilvestro P, Spirtos N, Cosgrove C, Sfakianos G, Liu JR, Vargas R, Shahin M, Corr B, Dessources K, Ueland F, Warshal D, Gillen J, Secord AA. Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258. Gynecol Oncol. 2025 Feb;193:119-129. doi: 10.1016/j.ygyno.2025.01.006. Epub 2025 Jan 23. PMID: 39854806; PMCID: PMC11929956. 
23. Kra JA, Markosian C, Tang FHF, de León AB, Chundury A, Agarwalla PK, Staquicini DI, Pasqualini R, Arap W. Brain-derived textiloma post glioblastoma resection and application of oxidized regenerated cellulose: A pilot, bedside-to-bench, translational study. Brain Pathol. 2025 Jul;35(4):e13331. doi: 10.1111/bpa.13331. Epub 2025 Jan 21. PMID: 39838550; PMCID: PMC12145898. 
24. Sarria GR, Baldeon D, Payet E, Li B, Gkika E, Refaat T, Price P, Cordero L, Zubizarreta EH, Sarria GJ. Current availability of radiotherapy devices in Peru and artificial intelligence-based analysis for constructing a nationwide implementation plan. Radiother Oncol. 2025 Mar;204:110724. doi:10.1016/j.radonc.2025.110724. Epub 2025 Jan 19. PMID: 39832681. 
25. Tsiang JT, Germanwala AV, Smith H, Thakkar JP, Chundury AT, Prabhu VC. Commentary: Symptomatic Progression, Recurrence, and Long-Term Follow-Up of Patients With Intracranial Epidermoid Cysts. Neurosurgery. 2025 Jan 10;97(2):e44-e45. doi:   0.1227/neu.0000000000003346. PMID: 39791894. 
26. Mortazavi SMJ, Mortazavi SA, Welsh JS, Sihver L. Should We Fear A Wave of Cancers After the COVID-19 Pandemic? J Biomed Phys Eng. 2024 Dec 1;14(6):517-518. doi: 10.31661/jbpe.v0i0.2310-1679. PMID: 39726879; PMCID: PMC11668930. 
27. Kim M, Kang H, Rong Y. Future clinical medical physics division should have fewer medical physicists and more medical physics assistants. J Appl Clin Med Phys. 2025 Jan;26(1):e14592. doi: 10.1002/acm2.14592. Epub 2024 Dec 2. PMID:39620657; PMCID: PMC11713159. 
28. Tom MC, Nagpal S, Palmer JD, Breen WG, Pollom EL, Lehrer EJ, McGranahan TM, Shiue K, Chundury A, McClelland Iii S, Saeed H, Chang EL, Chiang VLS, Wang TJC, Knisely JPS, Chao ST, Milano MT. An update to the American Radium Society's appropriate use criteria of lower grade gliomas: Integration of IDH inhibitors. Radiother Oncol. 2025 Jan;202:110640. doi: 10.1016/j.radonc.2024.110640. Epub 2024 Nov 16. PMID: 39557126. 
29. Stiff PJ, Kertowidjojo E, Potkul RK, Banerjee S, Mehrotra S, Small W Jr, Stack MS, Drakes ML. Cabozantinib inhibits tumor growth in mice with ovarian cancer. Am J Cancer Res. 2024 Oct 15;14(10):4788-4802. doi: 10.62347/ZSWV1767. PMID: 39553221; PMCID: PMC11560812. 
30. Alkhani L, Luce JP, Mínguez Gabiña P, Roeske JC. Calculation of alpha particle single-event spectra using a neural network. Front Oncol. 2024 Oct 2;14:1394671. doi: 10.3389/fonc.2024.1394671. PMID: 39416463; PMCID: PMC11480074. 
31. Mortazavi SMJ, Bevelacqua JJ, Mortazavi SA, Rafiepour P, Welsh JS. Stephen Hawking's Warning on Contacting Aliens: A Physics Perspective on the Intelligence Trap. J Biomed Phys Eng. 2024 Oct 1;14(5):513-516. doi: 10.31661/jbpe.v0i0.2306-1625. PMID: 39391274; PMCID: PMC11462274. 
32. DeCesaris C, Wilson T, Kim J, Burt L, Grant J, Harkenrider MM, Huang J, Jhingran A, Kidd E, Konski A, Lin L, Small W Jr, Suneja G, Gaffney D. Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial. Pract Radiat Oncol. 2024 Nov-Dec;14(6):e500-e506. doi: 10.1016/j.prro.2024.07.006. Epub 2024 Sep 13. PMID: 39269405. 
33. Saripalli AL, Venkatesulu BP, Nickols NG, Valle LF, Harkenrider MM, Kishan AU, Solanki AA. Systematic review and recommendations for re-irradiation for intraprostatic radiorecurrent prostate cancer after definitive radiation therapy. World J Urol. 2024 Sep 12;42(1):520. doi: 10.1007/s00345-024-05205-9. PMID: 39264453. 
34. Creutzberg CL, Kim JW, Eminowicz G, Allanson E, Eberst L, Kim SI, Nout RA, Park JY, Lorusso D, Mileshkin L, Ottevanger PB, Brand A, Mezzanzanica D, Oza A, Gebski V, Pothuri B, Batley T, Gordon C, Mitra T, White H, Howitt B, Matias-Guiu X, Ray-Coquard I, Gaffney D, Small W Jr, Miller A, Concin N, Powell MA, Stuart G, Bookman MA; participants of the 2023 Gynecologic Cancer InterGroup Endometrial Cancer Consensus Conference on Clinical Research. Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup. Lancet Oncol. 2024 Sep;25(9):e420-e431. doi: 10.1016/S1470-2045(24)00192-X. PMID: 39214113. 
35. Solanki AA, Zheng K, Skipworth AN, Robin LM, Leparski RF, Henry E, Rettig M, Salama JK, Ritter T, Jones J, Quek M, Chang M, Block AM, Welsh JS, Kumar A, Chao HH, Chen AC, Shapiro R, Bitting RL, Kwon R, Stross W, Puckett L, Wong YN, Nickols NG, Carlson K; VA STARPORT Investigators Group. Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the United States Veterans Affairs Health Care System: The VA STARPORT Experience. Curr Oncol. 2024 Aug 21;31(8):4781-4794. doi: 10.3390/curroncol31080358. PMID: 39195341; PMCID: PMC11353739. 
36. Tsui T, Podgorsak A, Roeske JC, Small W Jr, Refaat T, Kang H. Geometric and dosimetric evaluation for breast and regional nodal auto-segmentation structures. J Appl Clin Med Phys. 2024 Oct;25(10):e14461. doi: 10.1002/acm2.14461. Epub 2024 Aug 2. PMID: 39092893; PMCID: PMC11466470. 
37. Hekman L, Barrett A, Ross D, Palaganas E, Giridhar P, Elumalai T, V P, Block AM, Welsh JS, Harkenrider MM, Saini S, Roy S, Farooq A, Gupta G, Hsieh CE, Venkatesulu B, Solanki AA. A Systematic Review of Clinical Trials Comparing Radiation Therapy Versus Radical Prostatectomy in Prostate Cancer. Clin Genitourin Cancer. 2024 Oct;22(5):102157. doi: 10.1016/j.clgc.2024.102157. Epub 2024 Jul 11. PMID: 39084158. 
38. Welsh JS, Karam PA, Gale RP. Radiation exposure and space exploration. Leukemia. 2024 Sep;38(9):1870-1871. doi: 10.1038/s41375-024-02270-2. Epub 2024 Jun 10. PMID: 38858599. 
39. Anker CJ, Tchelebi LT, Selfridge JE, Jabbour SK, Akselrod D, Cataldo P, Abood G, Berlin J, Hallemeier CL, Jethwa KR, Kim E, Kennedy T, Lee P, Sharma N, Small W Jr, Williams VM, Russo S. Executive Summary of the American Radium Society on Appropriate Use Criteria for Nonoperative Management of Rectal Adenocarcinoma: Systematic Review and Guidelines. Int J Radiat Oncol Biol Phys. 2024 Nov 15;120(4):946-977. doi: 10.1016/j.ijrobp.2024.05.019. Epub 2024 May 25. PMID: 38797496. 
40. Klopp AH, Enserro D, Powell M, Randall M, Schink JC, Mannel RS, Holman L, Bender D, Kushnir CL, Backes F, Zweizig SL, Waggoner S, Bradley KA, Lawrence LD, Hanjani P, Darus CJ, Small W Jr, Cardenes HR, Feddock JM, Miller DS. Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial. J Clin Oncol. 2024 Jul 10;42(20):2425-2435. doi: 10.1200/JCO.23.01279. Epub 2024 Apr 25. PMID: 38662968; PMCID: PMC11681946. 

Other CBCC-Affiliated Publications July 1, 2024 – June 30, 2025  

1. Sparano JA, Crager M, Gray RJ, Tang G, Hoag J, Baehner FL, Shak S, Makower DF, Albain KS, Hayes DF, Geyer CE, Dees EC, Goetz MP, Olson JA, Lively T, Badve SS, Saphner TJ, Whelan TJ, Kaklamani VG, Wolmark N, Sledge GW, Stemmer SM. Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival. NEJM Evid. 2024 Aug;3(8):EVIDoa2300267. doi: 10.1056/EVIDoa2300267. Epub 2024 Jul 23. PMID: 39041867; PMCID: PMC11730053.
2. Tsiang JT, Germanwala AV, Smith H, Thakkar JP, Chundury AT, Prabhu VC. Commentary: Symptomatic Progression, Recurrence, and Long-Term Follow-Up of Patients With Intracranial Epidermoid Cysts. Neurosurgery. 2025 Jan 10;97(2):e44-e45. doi: 10.1227/neu.0000000000003346. PMID: 39791894.
3. Trapdoor” Medial Scapula Osteotomy for Resection of a Benign Subscapular Neoplasm: A Case Report.
4. Williams VM, Hallemeier CL, Jethwa KR, Selfridge JE, Shah P, Anker CJ, Abood G, Akselrod D, Berlin J, Kim E, Kennedy T, Lee P, Sharma N, William S Jr, Tchelebi L, Russo S; Expert Panel Management of Cervical Esophageal Cancer. Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus: Systematic Review and Guidelines. Am J Clin Oncol. 2025 Apr 1;48(4):163-179. doi: 10.1097/COC.0000000000001165. Epub 2025 Feb 6. PMID: 39912327.
5. Chen VS, James C, Khemmani M, Desai S, Doshi C, Rac G, Ellis JL, Patel HD, Barkan GA, Gupta GN, Flanigan RC, Wolfe AJ. A prospective evaluation of the prostate microbiome in malignant and benign tissue using transperineal biopsy. Prostate. 2024 Sep;84(13):1251-1261. doi: 10.1002/pros.24763. Epub 2024 Jun 30. PMID: 38946139.
6. Bergqvist M, Nordmark A, Williams A, Paoletti C, Barlow W, Cobain EF, Mehta RS, Gralow JR, Hortobagyi GN, Albain KS, Pusztai L, Sharma P, Godwin AK, Thompson AM, Hayes DF, Rae JM. Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226). Biomarkers. 2023 May;28(3):313-322. doi: 10.1080/1354750X.2023.2168063. Epub 2023 Jan 29. PMID: 36647745; PMCID: PMC10681159.
7. Thakkar JP, Luy DD, Pickles A, Refaat T, Prabhu VC. Chronic Neurological Complications of Brain Tumors and Brain Tumor Treatments. Curr Neurol Neurosci Rep. 2025 Mar 21;25(1):26. doi: 10.1007/s11910-025-01411-z. PMID: 40116979.
8. Riegel DC, Kwarteng JL, Pinsoneault L, Contreras S, Wasserman E, Visotcky A, Manriquez Prado A, Villarreal Espinosa O, Sheean P, Tovar M, Jensik K, Vidaver RM, Stolley MR. Implementation and Efficacy of Total Wellness: A Community-Based Cancer Prevention and Lifestyle Intervention Program. J Cancer Educ. 2025 Mar 29. doi: 10.1007/s13187-025-02589-z. Epub ahead of print. PMID: 40156663.
9. Early Breast Cancer Trialists' Collaborative Group (Albain, KS Steering Committee Member). Electronic address: bc.overview@ctsu.ox.ac.uk. Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009: a pooled analysis of 155 746 women in 151 trials. Lancet. 2024 Oct 12;404(10461):1407-1418. doi: 10.1016/S0140-6736(24)01745-8. Erratum in: Lancet. 2025 May 24;405(10492):1816. doi: 10.1016/S0140-6736(25)01045-1. PMID: 39396348.
10. Abdou Y, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Chia SKL, Dhesy-Thind S, Rastogi P, Alba E, Delaloge S, Schott AF, Shak S, Sharma P, Lew DL, Miao J, Unger JM, Tripathy D, Hortobagyi GN, Pusztai L, Kalinsky K. Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial. J Natl Cancer Inst. 2025 May 1;117(5):889-897. doi: 10.1093/jnci/djae314. PMID: 39656951; PMCID: PMC12058262.
11. Pusztai L, Hoag JR, Albain KS, Barlow WE, Stemmer SM, Meisner A, Hortobagyi GN, Shak S, Rae JM, Baehner R, Sharma P, Kalinsky KM. Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer. J Clin Oncol. 2025 Mar 10;43(8):919-928. doi: 10.1200/JCO-24-01507. Epub 2024 Dec 2. PMID: 39621968; PMCID: PMC11885031.
12. Kim S, Schaerth J, Chen K, Stull W, Yakoub G. Adenocarcinoma of Müllerian origin developed 22 years after Salpingo-oophorectomy in a woman with BRCA1 mutation: a thought about modification of chemotherapy dose and peritoneal resection. Oxf Med Case Reports. 2025 Jun 27;2025(6):omaf075. doi: 10.1093/omcr/omaf075. PMID: 40585440; PMCID: PMC12202305.
13. Tsiang JT, Germanwala AV, Smith H, Thakkar JP, Chundury AT, Prabhu VC. Commentary: Symptomatic Progression, Recurrence, and Long-Term Follow-Up of Patients With Intracranial Epidermoid Cysts. Neurosurgery. 2025 Jan 10;97(2):e44-e45. doi: 10.1227/neu.0000000000003346. PMID: 39791894.
14. Kim S, Mikami A, Stull W. Hairy Cell Leukemia With Splenic Rupture: Hematological Changes and Disappearance of Hairy Morphology After Splenectomy. J Hematol. 2025 Jun;14(3):139-145. doi: 10.14740/jh2045. Epub 2025 Apr 16. PMID: 40501519; PMCID: PMC12151096.
15. Chen K, Lee B, Kim S. Missed Follow-Up and Kaposi Sarcoma Progression: The Consequences of Medication Non-adherence. Cureus. 2025 May 15;17(5):e84196. doi: 10.7759/cureus.84196. PMID: 40385251; PMCID: PMC12081165.
16. Vasilopoulos A, Pohlman A, Odeh A, Shen KR, Coughlin JM, Abdelsattar ZM. Cost-Effectiveness of Adjuvant Osimertinib With and Without Chemotherapy for Surgically Resected NSCLC. JTO Clin Res Rep. 2025 Apr 9;6(6):100833. doi: 10.1016/j.jtocrr.2025.100833. PMID: 40420866; PMCID: PMC12104649.
17. Park SS, Verm RA, Abdelsattar ZM, Luchette FA, Baker TB, Baker MS. Are Access Costs and Income Associated With Treatment Decision-Making and Clinical Outcomes in Rural Patients Presenting With Upper Gastrointestinal Malignancy? J Surg Oncol. 2025 Jul;132(1):70-79. doi: 10.1002/jso.28140. Epub 2025 May 15. PMID: 40375434; PMCID: PMC12311405.
18. Pohlman A, Odeh B, Abdelsattar ZM. Robotic resection of a mediastinal liposarcoma. Multimed Man Cardiothorac Surg. 2025 Mar 31;2025. doi: 10.1510/mmcts.2025.013. PMID: 40160124.
19. Gowin K, Ahn ER, Lopez AM. Synthesis and Educational Overview of the ASCO-Society of Integrative Oncology Guidelines: On the Path to Implementation. Am Soc Clin Oncol Educ Book. 2025 Jun;45(3):e471830. doi: 10.1200/EDBK-25-471830. Epub 2025 Jun 26. PMID: 40570266.
20. McLaughlin Q, Sojka DK, Kennedy K, Piersma SJ, Sethakorn N. Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances. J Exp Clin Cancer Res. 2025 Aug 23;44(1):251. doi: 10.1186/s13046-025-03503-7. PMID: 40849493; PMCID: PMC12374365.
21. Sánchez-de-Diego C, Yada RC, Sethakorn N, Geiger PG, Ding AB, Heninger E, Ahmed F, Virumbrales-Muñoz M, Lupsa N, Bartels E, Stewart K, Ponik SM, Sharifi MN, Lang JM, Beebe DJ, Kerr SC. Engineering the bone metastatic prostate cancer niche through a microphysiological system to report patient-specific treatment response. Commun Biol. 2025 Jul 1;8(1):961. doi: 10.1038/s42003-025-08384-2. PMID: 40596459; PMCID: PMC12218145.
22. Kim S, Clark JI. Immunotherapy With Pembrolizumab for Resectable dMMR/MSI-H Stage III Colon Cancer: A Case of Personalized, Precision Surgery-Sparing Immunotherapy. J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251368093. doi: 10.1177/23247096251368093. Epub 2025 Aug 22. PMID: 40842405; PMCID: PMC12374102.
23. Kim S, Chen K, Stull W. Fluconazole-induced drug rash with eosinophilia and systemic symptoms syndrome: a case report. J Med Case Rep. 2025 May 29;19(1):257. doi: 10.1186/s13256-025-05321-z. PMID: 40442803; PMCID: PMC12123835.
24. Nelson AJ, Tatematsu BK, Beach JR, Sojka DK, Wu YL. Lung-resident memory B cells maintain allergic IgE responses in the respiratory tract. Immunity. 2025 Apr 8;58(4):875-888.e8. doi: 10.1016/j.immuni.2025.03.001. Epub 2025 Mar 25. PMID: 40139187; PMCID: PMC12068553.

Cancer Biology and Therapeutics Research Program - Affiliated Publications

1. Johnson M, Bell A, Lauing KL, Ladomersky E, Zhai L, Penco-Campillo M, Shah Y, Mauer E, Xiu J, Nicolaides T, Drumm M, McCortney K, Elemento O, Kim M, Bommi P, Low JT, Memon R, Wu J, Zhao J, Mi X, Glantz MJ, Sengupta S, Castro B, Yamini B, Horbinski C, Baker DJ, Walunas TL, Schiltz GE, Lukas RV, Wainwright DA. Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence. Clin Cancer Res. 2023 Dec 1;29(23):4973-4989. doi: 10.1158/1078-0432.CCR-23-0834. PMID: 37725593; PMCID: PMC10690140. 
2. Siddiqui A, Ross D, Jani RH, Prabhu VC, Lo S, Wainwright DA, Rouse S, Refaat T, Zhu Y, Thakkar JP. Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancer. Clin Exp Neuroimmunol. 2024 Feb;15(1):55-60. doi: 10.1111/cen3.12767. Epub 2023 Sep 18. PMID: 38595690; PMCID: PMC11003753. 
3. Rabin EE, Huang J, Kim M, Mozny A, Lauing KL, Penco-Campillo M, Zhai L, Bommi P, Mi X, Power EA, Prabhu VC, Anderson DE, Barton KP, Walunas TL, Schiltz GE, Amidei C, Sanchez-Gomez P, Thakkar JP, Lukas RV, Wainwright DA. Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma. Brain Behav Immun Health. 2024 Mar 15;38:100753. doi: 10.1016/j.bbih.2024.100753. PMID: 38600951; PMCID: PMC11004500. 
4. de Dios O, Ramírez-González MA, Gómez-Soria I, Segura-Collar B, Manosalva J, Megías D, De Andrea CE, Fernández-Rubio L, Hernández-Laín A, Sepúlveda-Sánchez JM, Rodriguez-Ruiz ME, Pérez-Núñez Á, Wainwright DA, Gargini R, Sánchez-Gómez P. NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma. J Immunother Cancer. 2024 Aug 30;12(8):e009210. doi: 10.1136/jitc-2024-009210. PMID: 39214651; PMCID: PMC11367385. 
5. Kostlan RJ, Phoenix JT, Budreika A, Ferrari MG, Khurana N, Choi JE, Juckette K, Mahapatra S, McCollum BL, Moskal R, Mannan R, Qiao Y, Vander Griend DJ, Chinnaiyan AM, Kregel S. Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation. Mol Cancer Res. 2024 Sep 4;22(9):826-839. doi: 10.1158/1541-7786.MCR-23-0904. PMID: 38820127; PMCID: PMC11372372. 
6. Phoenix JT, Budreika A, Kostlan RJ, Hwang JH, Fanning SW, Kregel S. Editorial: Hormone resistance in cancer. Front Endocrinol (Lausanne). 2023 Aug 24;14:1272932. doi: 10.3389/fendo.2023.1272932. PMID: 37693345; PMCID: PMC10484586. 
7. Williams A, Gutgesell L, de Wet L, Selman P, Dey A, Avineni M, Kapoor I, Mendez M, Brown R, Lamperis S, Blajszczak C, Bueter E, Kregel S, Vander Griend DJ, Szmulewitz RZ. SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis. Cancer Lett. 2023 Jul 1;565:216209. doi: 10.1016/j.canlet.2023.216209. Epub 2023 May 9. PMID: 37169162. 
8. Vellky JE, Kirkpatrick BJ, Gutgesell LC, Morales M, Brown RM, Wu Y, Maienschein-Cline M, Notardonato LD, Weinfeld MS, Nguyen RH, Brister E, Sverdlov M, Liu L, Xu Z, Kregel S, Nonn L, Vander Griend DJ, Reizine NM. ERBB3 Overexpression is Enriched in Diverse Patient Populations with Castration-sensitive Prostate Cancer and is Associated with a Unique AR Activity Signature. Clin Cancer Res. 2024 Apr 15;30(8):1530-1543. doi: 10.1158/1078-0432.CCR-23-2161. PMID: 38306015; PMCID: PMC11016893. 
9. Safi R, Wardell SE, Watkinson P, Qin X, Lee M, Park S, Krebs T, Dolan EL, Blattler A, Tsuji T, Nayak S, Khater M, Fontanillo C, Newlin MA, Kirkland ML, Xie Y, Long H, Fink EC, Fanning SW, Runyon S, Brown M, Xu S, Owzar K, Norris JD, McDonnell DP. Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells. Nat Commun. 2024 Sep 3;15(1):7675. doi: 10.1038/s41467-024-52032-y. PMID: 39227594; PMCID: PMC11371910. 
10. Young KS, Hancock GR, Fink E, Zigrossi A, Flowers B, Cooper DA, Nguyen VT, Martinez M, Mon KS, Bosland M, Zak D, Runde A, Sharifi MN, Kastrati I, Minh DDL, Kregel S, Fanning SW. Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S ESR1 Mutant Breast Cancer Cells. Res Sq [Preprint]. 2024 Jun 25:rs.3.rs-4542467. doi: 10.21203/rs.3.rs-4542467/v1. PMID: 38978585; PMCID: PMC11230492. 
11. Vidana Gamage HE, Albright ST, Smith AJ, Farmer R, Shahoei SH, Wang Y, Fink EC, Jacquin E, Weisser E, Bautista RO, Henn MA, Schane CP, Nelczyk AT, Ma L, Das Gupta A, Bendre SV, Nguyen T, Tiwari S, Krawczynska N, He S, Tjoanda E, Chen H, Sverdlov M, Gann PH, Boidot R, Vegran F, Fanning SW, Apetoh L, Hergenrother PJ, Nelson ER. Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells. Cancer Lett. 2024 Aug 10;597:217086. doi: 10.1016/j.canlet.2024.217086. Epub 2024 Jun 27. PMID: 38944231. 
12. Vidana Gamage HE, Shahoei SH, Wang Y, Jacquin E, Weisser E, Bautista RO, Henn MA, Schane CP, Nelczyk AT, Ma L, Das Gupta A, Bendre SV, Nguyen T, Tiwari S, Tjoanda E, Krawczynska N, He S, Albright ST, Farmer R, Smith AJ, Fink EC, Chen H, Sverdlov M, Gann PH, Boidot R, Vegran F, Fanning SW, Hergenrother PJ, Apetoh L, Nelson ER. NR0B2 re-educates myeloid immune cells to reduce regulatory T cell expansion and progression of breast and other solid tumors. Cancer Lett. 2024 Aug 10;597:217042. doi: 10.1016/j.canlet.2024.217042. Epub 2024 Jun 20. PMID: 38908543. 
13. Young KS, Hancock GR, Fink E, Zigrossi A, Flowers B, Cooper DA, Nguyen VT, Martinez M, Mon KS, Bosland M, Zak D, Runde A, Sharifi MN, Kastrati I, Minh DDL, Kregel S, Fanning SW. Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S ESR1 Mutant Breast Cancer Cells. bioRxiv [Preprint]. 2024 Jun 2:2024.05.28.596307. doi: 10.1101/2024.05.28.596307. PMID: 38854123; PMCID: PMC11160638. 
14. Hancock GR, Gertz J, Jeselsohn R, Fanning SW. Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies. Endocrinology. 2024 Apr 29;165(6):bqae051. doi: 10.1210/endocr/bqae051. PMID: 38643482; PMCID: PMC11075793. 
15. Gamage HEV, Shahoei SH, Albright ST, Wang Y, Smith AJ, Farmer R, Fink EC, Jacquin E, Weisser E, Bautista RO, Henn MA, Schane CP, Nelczyk AT, Ma L, Gupta AD, Bendre SV, Nguyen T, Tiwari S, Krawczynska N, He S, Tjoanda E, Chen H, Sverdlov M, Gann PH, Boidot R, Vegran F, Fanning SW, Apetoh L, Hergenrother PJ, Nelson ER. Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progression. bioRxiv [Preprint]. 2023 Aug 14:2023.08.14.553229. doi: 10.1101/2023.08.14.553229. PMID: 37645737; PMCID: PMC10462080. 
16. Ardini M, Aboagye SY, Petukhova VZ, Kastrati I, Ippoliti R, Thatcher GRJ, Petukhov PA, Williams DL, Angelucci F. The "Doorstop Pocket" In Thioredoxin Reductases─An Unexpected Druggable Regulator of the Catalytic Machinery. J Med Chem. 2024 Sep 9. doi: 10.1021/acs.jmedchem.4c00669. Epub ahead of print. PMID: 39250602. 
17. Bera S, Kadkol S, Hong LK, Ali W, Brockman JD, Sverdlov M, Brister E, Macais V, Kajdacsy-Balla A, Valyi-Nagy K, Xu Z, Kastrati I, Liu L, Diamond AM. Regulation of SELENOF translation by eIF4a3: Possible role in prostate cancer progression. Mol Carcinog. 2023 Dec;62(12):1803-1816. doi: 10.1002/mc.23616. Epub 2023 Aug 9. PMID: 37555760. 
18. Ekyalongo RC, Flowers B, Sharma T, Zigrossi A, Zhang A, Quintanilla-Arteaga A, Singh K, Kastrati I. SELENOF Controls Proliferation and Cell Death in Breast-Derived Immortalized and Cancer Cells. Cancers (Basel). 2023 Jul 19;15(14):3671. doi: 10.3390/cancers15143671. PMID: 37509331; PMCID: PMC10377602. 
19. Sharma T, Zhang Y, Zigrossi A, Cravatt BF, Kastrati I. Dimethyl fumarate inhibits ZNF217 and can be beneficial in a subset of estrogen receptor positive breast cancers. Breast Cancer Res Treat. 2023 Oct;201(3):561-570. doi: 10.1007/s10549-023-07037-4. Epub 2023 Jul 21. PMID: 37477798. 
20. Perez C, Plaza-Rojas L, Boucher JC, Nagy MZ, Kostenko E, Prajapati K, Burke B, Reyes MD, Austin AL, Zhang S, Le PT, Guevara-Patino JA. NKG2D receptor signaling shapes T cell thymic education. J Leukoc Biol. 2024 Jan 19;115(2):306-321. doi: 10.1093/jleuko/qiad130. PMID: 37949818. 
21. Barisic S, Brahmbhatt EM, Cherkasova E, Spear TT, Savani U, Pierre S, Scurti GM, Chen L, Igboko M, Nadal R, Zeng G, Parry G, Stroncek DF, Highfill S, Dalheim AV, Reger R, Nishimura MI, Childs RW. Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus. J Immunother Cancer. 2024 Sep 11;12(9):e009147. doi: 10.1136/jitc-2024-009147. PMID: 39266213. 
22. Kalinski P, Kokolus KM, Azrak R, Berezin MY, Brentjens R, Czerniecki B, Dubrov S, Eaton K, Hyland A, Kisailus A, Kortylewski M, Koski GK, Kotula L, Gandhi S, Griffiths EA, Ługowska I, Matosevic S, McAleer C, Mikuła M, Nishimura MI, Noyes K, Orabina T, Ozretić P, Paragh G, Parascandola M, Pašukonienė V, Perl A, Powell DJ Jr, Priebe W, Repasky EA, Rudnicki M, Singh AK, Sarnowska E, Sužiedėlis K, Titkova A, Utz K, Wei WZ, Rutkowski P. MEETING HIGHLIGHTS: THE THIRD MARIE SKŁODOWSKA-CURIE SYMPOSIUM ON CANCER RESEARCH AND CARE AT ROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, SEPTEMBER 20-22, 2023. Wiad Lek. 2023;76(12):2543-2555. doi: 10.36740/WLek202312101. PMID: 38290016. 
23. Wang SY, Scurti GM, Dalheim AV, Quinn S, Stiff PJ, Nishimura MI. Nonactivated and IL-7 cultured CD19-specific CAR T cells are enriched in stem cell phenotypes and functionally superior. Blood Adv. 2024 Jan 23;8(2):324-335. doi: 10.1182/bloodadvances.2023010607. PMID: 37967375; PMCID: PMC10788799. 
24. Nguyen MR, Ma E, Wyatt D, Knight KL, Osipo C. The effect of an exopolysaccharide probiotic molecule from Bacillus subtilis on breast cancer cells. Front Oncol. 2023 Nov 23;13:1292635. doi: 10.3389/fonc.2023.1292635. PMID: 38074643; PMCID: PMC10702531. 
25. Keating CR, Calvisi DF, Qiu W. High-fat diet-induced AKT-palmitoylation in hepatocellular carcinoma: a breakthrough mechanistic investigation. Gut. 2024 Jun 6;73(7):1046-1048. doi: 10.1136/gutjnl-2023-331857. PMID: 38336464; PMCID: PMC11156549. 
26. Hou W, Gad SA, Ding X, Dhanarajan A, Qiu W. Focal adhesion kinase confers lenvatinib resistance in hepatocellular carcinoma via the regulation of lysine-deficient kinase 1. Mol Carcinog. 2024 Jan;63(1):173-189. doi: 10.1002/mc.23644. Epub 2023 Oct 3. PMID: 37787401; PMCID: PMC10842616. 
27. Buttell A, Qiu W. The action and resistance mechanisms of Lenvatinib in liver cancer. Mol Carcinog. 2023 Dec;62(12):1918-1934. doi: 10.1002/mc.23625. Epub 2023 Sep 6. PMID: 37671815; PMCID: PMC10840925. 
28. Malnassy G, Keating CR, Gad S, Bridgeman B, Perera A, Hou W, Cotler SJ, Ding X, Choudhry M, Sun Z, Koleske AJ, Qiu W. Inhibition of Abelson Tyrosine-Protein Kinase 2 Suppresses the Development of Alcohol-Associated Liver Disease by Decreasing PPARgamma Expression. Cell Mol Gastroenterol Hepatol. 2023;16(5):685-709. doi: 10.1016/j.jcmgh.2023.07.006. Epub 2023 Jul 15. PMID: 37460041; PMCID: PMC10520367. 
29. Bala P, Rennhack JP, Aitymbayev D, Morris C, Moyer SM, Duronio GN, Doan P, Li Z, Liang X, Hornick JL, Yurgelun MB, Hahn WC, Sethi NS. Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation. Sci Adv. 2023 Mar 29;9(13):eadf0927. doi: 10.1126/sciadv.adf0927. Epub 2023 Mar 29. PMID: 36989360; PMCID: PMC10058311. 
30. Bassetti MF, Morris BA, Sethakorn N, Lang JM, Schehr JL, Zhao SG, Morris ZS, Buehler D, Eickhoff JC, Harari PM, Traynor AM, Campbell TC, Baschnagel AM, Leal TA. Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase 1b Trial. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1481-1489. doi: 10.1016/j.ijrobp.2023.11.040. Epub 2023 Dec 8. PMID: 38072321; PMCID: PMC10947887. 
31. Helzer KT, Sharifi MN, Sperger JM, Shi Y, Annala M, Bootsma ML, Reese SR, Taylor A, Kaufmann KR, Krause HK, Schehr JL, Sethakorn N, Kosoff D, Kyriakopoulos C, Burkard ME, Rydzewski NR, Yu M, Harari PM, Bassetti M, Blitzer G, Floberg J, Sjöström M, Quigley DA, Dehm SM, Armstrong AJ, Beltran H, McKay RR, Feng FY, O'Regan R, Wisinski KB, Emamekhoo H, Wyatt AW, Lang JM, Zhao SG. Fragmentomic analysis of circulating tumor DNA-targeted cancer panels. Ann Oncol. 2023 Sep;34(9):813-825. doi: 10.1016/j.annonc.2023.06.001. Epub 2023 Jun 16. PMID: 37330052; PMCID: PMC10527168. 
32. Hajihassani O, Zarei M, Roichman A, Loftus A, Boutros CS, Hue J, Naji P, Boyer J, Tahan S, Gallagher P, Beegan W, Choi J, Lei S, Kim C, Rathore M, Nakazzi F, Shah I, Lebo K, Cheng H, Mudigonda A, Alibeckoff S, Ji K, Graor H, Miyagi M, Vaziri-Gohar A, Brunengraber H, Wang R, Lund PJ, Rothermel LD, Rabinowitz JD, Winter JM. A Ketogenic Diet Sensitizes Pancreatic Cancer to Inhibition of Glutamine Metabolism. bioRxiv [Preprint]. 2024 Jul 23:2024.07.19.604377. doi: 10.1101/2024.07.19.604377. PMID: 39211182; PMCID: PMC11361133. 
33. Zarei M, Hajihassani O, Hue JJ, Loftus AW, J Graor H, Nakazzi F, Naji P, Boutros CS, Uppin V, Vaziri-Gohar A, Shalaby A, Asara JM, Rothermel LD, Brody JR, Winter JM. IDH1 inhibition potentiates chemotherapy efficacy in pancreatic cancer. Cancer Res. 2024 Jun 6. doi: 10.1158/0008-5472.CAN-23-1895. Epub ahead of print. PMID: 38843355. 
34. Subramani E, Dominic A, Bhattacharya PK, Frigo DE, Bederman I, Vaziri-Gohar A. Editorial: Metabolic regulation under oxidative stress in cancer. Front Oncol. 2023 Sep 12;13:1286086. doi: 10.3389/fonc.2023.1286086. PMID: 37771445; PMCID: PMC10523380. 
35. Vaziri-Gohar A, Hue JJ, Abbas A, Graor HJ, Hajihassani O, Zarei M, Titomihelakis G, Feczko J, Rathore M, Chelstowska S, Loftus AW, Wang R, Zarei M, Goudarzi M, Zhang R, Willard B, Zhang L, Kresak A, Willis JE, Wang GM, Tatsuoka C, Salvino JM, Bederman I, Brunengraber H, Lyssiotis CA, Brody JR, Winter JM. Increased glucose availability sensitizes pancreatic cancer to chemotherapy. Nat Commun. 2023 Jun 28;14(1):3823. doi: 10.1038/s41467-023-38921-8. PMID: 37380658; PMCID: PMC10307839. 
36. Jain KG, Liu Y, Zhao R, Muire PJ, Zhang J, Zang QS, Ji HL. Humanized L184Q Mutated Surfactant Protein C Gene Alters Alveolar Type 2 Epithelial Cell Fate. Int J Mol Sci. 2024 Aug 9;25(16):8723. doi: 10.3390/ijms25168723. PMID: 39201410; PMCID: PMC11354303. 
37. Liu S, Joshi K, Zhang L, Li W, Mack R, Runde A, Hagen PA, Barton K, Breslin P, Ji HL, Kini AR, Wang Z, Zhang J. Caspase 8 deletion causes infection/inflammation-induced bone marrow failure and MDS-like disease in mice. Cell Death Dis. 2024 Apr 18;15(4):278. doi: 10.1038/s41419-024-06660-3. PMID: 38637559; PMCID: PMC11026525. 
38. Ali G, Zhang M, Chang J, Zhao R, Jin Y, Zhang J, Ji HL. PAI-1 regulates AT2-mediated re-alveolarization and ion permeability. Stem Cell Res Ther. 2023 Jul 27;14(1):185. doi: 10.1186/s13287-023-03414-4. PMID: 37501095; PMCID: PMC10375781. 
39. Li Y, Seet CS, Mack R, Joshi K, Runde AP, Hagen PA, Barton K, Breslin P, Kini A, Ji HL, Zhang J. Distinct roles of hematopoietic cytokines in the regulation of leukemia stem cells in murine MLL-AF9 leukemia. Stem Cell Reports. 2024 Jan 9;19(1):100-111. doi: 10.1016/j.stemcr.2023.11.003. Epub 2023 Dec 14. PMID: 38101400; PMCID: PMC10828676. 
40. Fitzsimons J, Phelan K, Dhanarajan A. Hearing Loss in a Patient with Waldenstrom Macroglobulinemia Receiving Bortezomib. Case Rep Oncol. 2024 Jun 18;17(1):653-657. doi: 10.1159/000539453. PMID: 39015638; PMCID: PMC11249454. 
41. Delgado-Ramos GM, Fitzsimons J, Dhanarajan A. A narrative review of the evolving landscape of the management of metastatic gastric cancer: the role of targeted therapies. J Gastrointest Oncol. 2023 Dec 31;14(6):2600-2616. doi: 10.21037/jgo-23-464. Epub 2023 Dec 14. PMID: 38196524; PMCID: PMC10772679. 
42. Prasad Venkatesulu B, Ness E, Ross D, Saripalli AL, Abood G, Badami A, Cotler S, Dhanarajan A, Knab LM, Lee B, Molvar C, Sethi A, Small W Jr, Refaat T. MRI-guided Real-time Online Gated Stereotactic Body Radiation Therapy for Liver Tumors. Am J Clin Oncol. 2023 Dec 1;46(12):530-536. doi: 10.1097/COC.0000000000001042. Epub 2023 Sep 14. PMID: 37708212. 
43. Oluwole OO, Forcade E, Muñoz J, de Guibert S, Vose JM, Bartlett NL, Lin Y, Deol A, McSweeney P, Goy AH, Kersten MJ, Jacobson CA, Farooq U, Minnema MC, Thieblemont C, Timmerman JM, Stiff P, Avivi I, Tzachanis D, Zheng Y, Vardhanabhuti S, Nater J, Shen RR, Miao H, Kim JJ, van Meerten T. Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids. Bone Marrow Transplant. 2024 Mar;59(3):366-372. doi: 10.1038/s41409-023-02169-z. Epub 2024 Jan 4. PMID: 38177222; PMCID: PMC10920180. 
44. Hagen P, Norton J, Tsai S, Campo L, Lee M, Gomez K, Stiff P. Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma. Br J Haematol. 2024 Apr;204(4):1422-1428. doi: 10.1111/bjh.19281. Epub 2024 Jan 4. PMID: 38176404. 
45. Mumby P, Adams W, Smith S, Rao M, Stiff P. Pharmacotherapy for the Prevention of Depression and Behavioral Side Effects in Hematopoietic Stem Cell Transplantation Patients. Transplant Cell Ther. 2024 Mar;30(3):320.e1-320.e11. doi: 10.1016/j.jtct.2023.12.014. Epub 2023 Dec 24. PMID: 38147899. 
46. Kalinina O, Minter LM, Sperling AI, Hollinger MK, Le P, Osborne BA, Zhang S, Stiff P, Knight KL. Exopolysaccharide-Treated Dendritic Cells Effectively Ameliorate Acute Graft-versus-Host Disease. Transplant Cell Ther. 2024 Jan;30(1):79.e1-79.e10. doi: 10.1016/j.jtct.2023.10.023. Epub 2023 Nov 2. PMID: 37924979. 
47. Stiff PJ, Mehrotra S, Potkul RK, Banerjee S, Walker C, Drakes ML. Selinexor in Combination with Decitabine Attenuates Ovarian Cancer in Mice. Cancers (Basel). 2023 Sep 13;15(18):4541. doi: 10.3390/cancers15184541. PMID: 37760508; PMCID: PMC10526280. 
48. Shah BD, Cassaday RD, Park JH, Houot R, Oluwole OO, Logan AC, Boissel N, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff PJ, Jeyakumar D, Mao D, Adhikary S, Zhou L, Schuberth PC, Damico Khalid R, Ghobadia A. Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3. J Immunother Cancer. 2023 Aug;11(8):e007118. doi: 10.1136/jitc-2023-007118. PMID: 37648261; PMCID: PMC10471850. 
49. Szabolcs P, Mazor RD, Yackoubov D, Levy S, Stiff P, Rezvani A, Hanna R, Wagner J, Keating A, Lindemans CA, Karras N, McGuirk J, Hamerschlak N, López-Torija I, Sanz G, Valcarcel D, Horwitz ME. Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy. Transplant Cell Ther. 2023 Aug;29(8):517.e1-517.e12. doi: 10.1016/j.jtct.2023.04.018. Epub 2023 Apr 28. PMID: 37120136.

Radiation Oncology Imaging and Technology Research Program - Affiliated Publications 

1. Solanki AA, Burmeister J, Mak RH, Moran JM. Looking Backward and Forward: Learning From and Updating the ASTRO Safety White Papers 10 Years Later. Pract Radiat Oncol. 2023 Jul-Aug;13(4):278-281. doi: 10.1016/j.prro.2023.03.002. Epub 2023 May 10. PMID: 37162425. 
2. Sagae S, Toita T, Matsuura M, Saito M, Matsuda T, Sato N, Shimizu A, Endo T, Fujii M, Gaffney DK, Small W Jr. Improvement in radiation techniques for locally advanced cervical cancer during the last two decades. Int J Gynecol Cancer. 2023 Aug 7;33(8):1295-1303. doi: 10.1136/ijgc-2022-004230. PMID: 37041022; PMCID: PMC10423558. 
3. Podgorsak AR, Venkatesulu BP, Abuhamad M, Harkenrider MM, Solanki AA, Roeske JC, Kang H. Dosimetric and workflow impact of synthetic-MRI use in prostate high-dose-rate brachytherapy. Brachytherapy. 2023 Sep-Oct;22(5):686-696. doi: 10.1016/j.brachy.2023.05.005. Epub 2023 Jun 12. PMID: 37316376. 
4. Saripalli AL, Lee B, Adams W, Bhandare N, Venkatesulu BP, Yoo RK, Price J, Harmon GA, Block AM, Friedman N, Harkenrider MM, Major EJ, Small W Jr, Wagner RH, Welsh JS, Solanki AA. Multi-institutional Development and Validation of Contouring Guidelines for Para-aortic Elective Nodal Irradiation in Prostate Cancer Based on Patterns of Involvement on Targeted Molecular Imaging Positron Emission Tomography/Computed Tomography. Int J Radiat Oncol Biol Phys. 2023 Nov 1;117(3):630-640. doi: 10.1016/j.ijrobp.2023.05.017. Epub 2023 May 16. PMID:37201758. 
5. Mamikunian G, Ziegler A, Block A, Thorpe E. Risk Factors for Recurrence and the Role of Radiotherapy in Low-grade Myofibroblastic Sarcoma: A Systematic Review. Am J Clin Oncol. 2023 Sep 1;46(9):420-425. doi:10.1097/COC.0000000000001025. Epub 2023 Jun 26. PMID: 37358303. 
6. Hallemeier CL, Sharma N, Anker C, Selfridge JE, Lee P, Jabbour S, Williams V, Liu D, Kennedy T, Jethwa KR, Kim E, Kumar R, Small W Jr, Tchelebi L, Russo S. American Radium Society Appropriate Use Criteria for the use of liver-directed therapies for nonsurgical management of liver metastases: Systematic review and guidelines. Cancer. 2023 Oct 15;129(20):3193-3212. doi: 10.1002/cncr.34931. Epub 2023 Jul 6. PMID: 37409678. 
7. Kang H, Podgorsak AR, Venkatesulu BP, Saripalli AL, Chou B, Solanki AA, Harkenrider M, Shea S, Roeske JC, Abuhamad M. Prostate segmentation accuracy using synthetic MRI for high-dose-rate prostate brachytherapy treatment planning. Phys Med Biol. 2023 Jul 28;68(15). doi: 10.1088/1361-6560/ace674.PMID: 37433302. 
8. Hathout L, Erickson B, Gehrig P, Harkenrider M, Klopp A, Small W Jr. Can Immunotherapy Replace Radiation in Locally Advanced Endometrial Cancer?: Treatment for Advanced Endometrial Cancer. Pract Radiat Oncol. 2023 Nov-Dec;13(6):551-557. doi: 10.1016/j.prro.2023.06.005. Epub 2023 Jul 11. PMID: 37442429. 
9. Oladeru OT, Dunn SA, Li J, Coles CE, Yamauchi C, Chang JS, Cheng SH, Kaidar- Person O, Meattini I, Ramiah D, Kirby A, Hijal T, Marta GN, Poortmans P, Isern- Verdum J, Zissiadis Y, Offersen BV, Refaat T, Elsayad K, Hijazi H, Dengina N, Belkacemi Y, Luo FD, Lu S, Griffin C, Collins M, Ryan P, Larios D, Warren LE, Punglia RS, Wong JS, Spiegel DY, Jagsi R, Taghian A, Bellon JR, Ho AY. Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case- Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic. JCO Glob Oncol. 2023 Jul;9:e2300010. doi: 10.1200/GO.23.00010. PMID:37471670; PMCID: PMC10581620. 
10. Ladbury C, Harkenrider M, Taunk N, Fisher C, Mayadev J, Venkat P, Yashar C, Gaffney D, Beriwal S, Glaser S. A practical guide to hybrid interstitial/intracavitary brachytherapy for locally-advanced cervical cancer. Brachytherapy. 2023 Sep-Oct;22(5):640-648. doi: 10.1016/j.brachy.2023.07.001. Epub 2023 Jul 20. PMID: 37481370. 
11. Gale RP, Welsh J, Karam PA. Why are haematopoietic stem cells in the bone marrow: ontology recapitulates phylogeny. Leukemia. 2023 Sep;37(9):1779-1781. doi: 10.1038/s41375-023-01986-x. Epub 2023 Jul 29. PMID: 37516786; PMCID: PMC10457178. 
12. Solanki AA, Yoo RK, Adams W, Davicioni E, Mysz ML, Shea S, Gupta GN, Showalter T, Garant A, Hentz C, Farooq A, Baldea K, Small W, Harkenrider MM. F-SHARP: a Phase I/II trial of focal salvage high-dose-rate brachytherapy for Radiorecurrent prostate cancer. BJU Int. 2024 Feb;133(2):188-196. doi: 10.1111/bju.16150. Epub 2023 Sep 15. PMID: 37562825. 
13. Hsieh RC, Chou YC, Hung CY, Lee LY, Venkatesulu BP, Huang SF, Liao CT, Cheng NM, Wang HM, Wu CE, Kang CJ, Chen MF, Cheng YF, Yeh KY, Wang CH, Chou WC, Lin CY. A multicenter retrospective analysis of patients with salivary gland carcinoma treated with postoperative radiotherapy alone or chemoradiotherapy. Radiother Oncol. 2023 Nov;188:109891. doi: 10.1016/j.radonc.2023.109891. Epub 2023 Sep 1. PMID: 37659659. 
14. Barry P, Beriwal S, Maheshwari E, Bhargava R, Small W Jr. Surveillance imaging for salvage therapy in endometrial cancer. Int J Gynecol Cancer. 2023 Sep 4;33(9):1464-1468. doi: 10.1136/ijgc-2023-004649. PMID: 37666541. 
15. Grover S, Lichter KE, Likhacheva A, Jang JW, Ning MS, Robin TP, Small W Jr, Kudchadker RJ, Swamidas J, Chopra S, Rai B, Sharma SD, Sharma DN, Kuppusamy T, Yang R, Berger D, Mendez LC, Glaser S, Erickson DL, Chino J, Mourtada F, Abdel- Wahab M, Jhingran A, Simonds H, Mahantshetty U. The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries. Brachytherapy. 2023 Nov- Dec;22(6):716-727. doi: 10.1016/j.brachy.2023.07.003. Epub 2023 Sep 12. PMID: 37704540. 
16. Prasad Venkatesulu B, Ness E, Ross D, Saripalli AL, Abood G, Badami A, Cotler S, Dhanarajan A, Knab LM, Lee B, Molvar C, Sethi A, Small W Jr, Refaat T. MRI-guided Real-time Online Gated Stereotactic Body Radiation Therapy for Liver Tumors. Am J Clin Oncol. 2023 Dec 1;46(12):530-536. doi: 10.1097/COC.0000000000001042. Epub 2023 Sep 14. PMID: 37708212. 
17. Hsieh RC, Lee CH, Huang HC, Wu SW, Chou CY, Hung SP, Lee CW, Krishnan S, Venkatesulu BP, Lee JC, Chou YC, Chan KM, Lin PT, Lee WC, Lin CC, Lin SY, Hong JH. Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective Analysis. Int J Radiat Oncol Biol Phys. 2024 Mar 1;118(3):712-724. doi: 10.1016/j.ijrobp.2023.09.049. Epub 2023 Sep 30. PMID: 37778426. 
18. Shimomura A, Wu T, Rusu I, Kishan AU, Tree AC, Solanki AA, Liauw SL. Monitoring Intrafraction Motion of the Prostate During Radiation Therapy: Suggested Practice Points From a Focused Review. Pract Radiat Oncol. 2024 Mar-Apr;14(2):146-153. doi: 10.1016/j.prro.2023.08.017. Epub 2023 Oct 22. PMID: 37875222. 
19. Ladbury C, Sueyoshi MH, Brovold NM, Kumar R, Andraos TY, Gogineni E, Kim M, Klopp A, Albuquerque K, Kunos C, Leung E, Mantz C, Biswas T, Beriwal S, Small W Jr, Erickson B, Gaffney D, Lo SS, Viswanathan AN. Stereotactic Body Radiation Therapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society Practice Review. Pract Radiat Oncol. 2024 May-Jun;14(3):252-266. doi: 10.1016/j.prro.2023.09.008. Epub 2023 Oct 22. PMID: 37875223. 
20. Mahesh M, Frush DP, Gros S, Dauer L, Barreto I, Ansari AJ. Proposed Priorities for Low-Dose Radiation Research and Their Relevance to the Practice of Radiology. Radiology. 2023 Nov;309(2):e222590. doi: 10.1148/radiol.222590.PMID: 37962507. 
21. deBettencourt MF, Liu Y, Cotler SJ, Molvar CA, Abdelrahman T, Thomas TO. SBRT vs. Y90: HCC Treatment Outcomes and Costs. Am J Clin Oncol. 2024 Mar 1;47(3):99-104. doi: 10.1097/COC.0000000000001064. Epub 2023 Nov 20. PMID: 37981697. 
22. Xu L, Jiang P, Tsui T, Liu J, Zhang X, Yu L, Niu T. 4D-CT deformable image registration using unsupervised recursive cascaded full-resolution residual networks. Bioeng Transl Med. 2023 Aug 22;8(6):e10587. doi: 10.1002/btm2.10587. PMID: 38023695; PMCID: PMC10658570. 
23. Expert Panel on Thoracic Imaging; Martin MD, Henry TS, Berry MF, Johnson GB, Kelly AM, Ko JP, Kuzniewski CT, Lee E, Maldonado F, Morris MF, Munden RF, Raptis CA, Shim K, Sirajuddin A, Small W Jr, Tong BC, Wu CC, Donnelly EF. ACR Appropriateness Criteria® Incidentally Detected Indeterminate Pulmonary Nodule. J Am Coll Radiol. 2023 Nov;20(11S):S455-S470. doi: 10.1016/j.jacr.2023.08.024. PMID: 38040464. 
24. Wallner PE, Yoo DC, Calais J, Escorcia FE, Mari Aparici C, Michalski J, Morris M, Morris ZS, Pryma D, Rabatic BM, Sharma N, Vapiwala N, Ghesani MV, Subramaniam RM, Small W Jr, Schechter NR. ACR-ACNM-ARS-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radiopharmaceuticals. Am J Clin Oncol. 2024 Apr 1;47(4):169-176. doi: 10.1097/COC.0000000000001072. Epub 2023  Dec 22. PMID: 38131352. 
25. Jethwa KR, Kim E, Berlin J, Anker CJ, Tchelebi L, Abood G, Hallemeier CL, Jabbour S, Kennedy T, Kumar R, Lee P, Sharma N, Small W Jr, Williams V, Russo S. Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma: Systematic Review and Guidelines. Am J Clin Oncol. 2024 Apr 1;47(4):185-199. doi: 10.1097/COC.0000000000001076. Epub 2023 Dec 22. PMID: 38131628. 
26. Saeed H, Wallner PE, Bates JE, Chundury A, Freedman LM, Mitin T, Walker GV, Small W Jr, Schechter NR. ACR-ARS Practice Parameter for Communication: Radiation Oncology. Am J Clin Oncol. 2024 May 1;47(5):210-216. doi: 10.1097/COC.0000000000001078. Epub 2023 Dec 25. PMID: 38149838. 
27. Lo S, Chao S, Harris E, Knisely J, Luh JY, Mohindra P, Quang TS, Ye J, Small W Jr, Schechter NR. ACR-ARS Practice Parameter for Radiation Oncology. Am J Clin Oncol. 2024 May 1;47(5):201-209. doi: 10.1097/COC.0000000000001079. Epub 2023 Dec 28. PMID: 38153244. 
28. Giridhar P, Pradhan S, Dokania S, Venkatesulu B, Sarode R, Welsh JS. Microbiome and Abdominopelvic Radiotherapy Related Chronic Enteritis: A Microbiome-based Mechanistic Role of Probiotics and Antibiotics. Am J Clin Oncol. 2024 May 1;47(5):246-252. doi: 10.1097/COC.0000000000001082. Epub 2024 Jan 9. PMID: 38193365. 
29. Chou B, Lee JH, Saetern L, Venkatesulu BP, Welsh JS, Harkenrider MM. Bombarding Oligoprogression: Oncologic Outcomes After Radiation to Patients With Oligoprogressive Non-Small Cell Lung Cancer on Maintenance Systemic Therapy. Am J Clin Oncol. 2024 Apr 1;47(4):155-160. doi: 10.1097/COC.0000000000001077. Epub 2024 Jan 9. PMID: 38193499. 
30. Sethi A, Gros S, Brodin P, Ghavidel B, Chai X, Popovic M, Tomé WA, TrichterS, Yang X, Zhang H, Uhl V. Intraoperative radiation therapy with 50 kV x-rays: A multi-institutional review. J Appl Clin Med Phys. 2024 Mar;25(3):e14272. doi: 10.1002/acm2.14272. Epub 2024 Jan 26. PMID: 38279520; PMCID: PMC10929998. 
31. Sozio SJ, Jhawar SR, Li S, Liu H, Sayan M, Parikh R, Chundury A, Kim S. Prognosis of South Asian Buccal Mucosa Cancer Patients in the United States: Association of Race with Overall Survival. Asian Pac J Cancer Prev. 2024 Jan 1;25(1):241-248. doi: 10.31557/APJCP.2024.25.1.241. PMID: 38285790; PMCID: PMC10911709. 
32. Saripalli AL, Ross DH, Murphy E, Gomez K, Thilges S, Harkenrider MM. Prevalence of trauma history and symptoms in patients who have received vaginal brachytherapy as part of their endometrial cancer treatment. Gynecol Oncol. 2024 Jun;185:68-74. doi: 10.1016/j.ygyno.2024.02.007. Epub 2024 Feb 17. PMID: 38368815. 
33. Mirian C, Jensen LR, Juratli TA, Maier AD, Torp SH, Shih HA, Morshed RA, Young JS, Magill ST, Bertero L, Stummer W, Spille DC, Brokinkel B, Oya S, Miyawaki S, Saito N, Proescholdt M, Kuroi Y, Gousias K, Simon M, Moliterno J, Prat-Acin R, Goutagny S, Prabhu VC, Tsiang JT, Wach J, Güresir E, Yamamoto J, Kim YZ, Lee JH, Koshy M, Perumal K, Baskaya MK, Cannon DM, Shrieve DC, Suh CO, Chang JH, Kamenova M, Straumann S, Soleman J, Eyüpoglu IY, Catalan T, Lui A, Theodosopoulos PV, McDermott MW, Wang F, Guo F, Góes P, de Paiva Neto MA, Jamshidi A, Komotar R, Ivan M, Luther E, Souhami L, Guiot MC, Csonka T, Endo T, Barrett OC, Jensen R, Gupta T, Patel AJ, Klisch TJ, Kim JW, Maiuri F, Barresi V, Tabernero MD, Skyrman S, Broechner A, Bach MJ, Law I, Scheie D, Kristensen BW, Munch TN, Meling T, Fugleholm K, Blanche P, Mathiesen T. The importance of considering competing risks in recurrence analysis of intracranial meningioma. J Neurooncol. 2024 Feb;166(3):503-511. doi: 10.1007/s11060-024-04572-y. Epub 2024 Feb 10. PMID: 38336917; PMCID: PMC10876814. 
34. Rithidech KN, Peanlikhit T, Honikel L, Li J, Liu J, Karakach T, Zimmerman T, Welsh J. Consumption of Apigenin Prevents Radiation-induced Gut Dysbiosis in Male C57BL/6J Mice Exposed to Silicon Ions. Radiat Res. 2024 Apr 1;201(4):317-329. doi: 10.1667/RADE-23-00110.1. PMID: 38373016. 
35. Ross D, Chan D, Kuo E, Harkenrider M. Thoracic Reirradiation with Stereotactic Body Radiation Therapy (SBRT) for Recurrent Advanced Non-Small Cell Lung Cancer (NSCLC). Pract Radiat Oncol. 2024 May-Jun;14(3):234-240. doi:10.1016/j.prro.2024.02.001. Epub 2024 Feb 21. PMID: 38387781. 
36. Keeler A, Lehmann M, Luce J, Kaur M, Roeske J, Kang H. Technical note: TIGRE-DE for the creation of virtual monoenergetic images from dual-energy cone-beam CT. Med Phys. 2024 Apr;51(4):2975-2982. doi: 10.1002/mp.17002. Epub 2024Feb 26. PMID: 38408013; PMCID: PMC10994758. 
37. Nickols NG, Tsai S, Kane N, Tran S, Ghayouri L, Diaz-Perez S, Thein M, Anderson-Berman N, Eason J, Kishan AU, Steinberg ML, Reiter RE, Lee SP, Gin GE, Kwon R, Chang MG, Chao HH, Solanki AA, Sexton R, Lewis M, Lorentz W, Cheung MK, Gage DL, Duriseti S, Valle L, Berenji G, Aronson WJ, Garraway IP, Rettig MB. Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer. Eur Urol. 2024 Mar 14:S0302-2838(24)00079-4. doi: 10.1016/j.eururo.2024.02.008. Epub ahead of print. PMID: 38490853. 
38. Ross DH, Gomez K, Harmon G, Mysz ML, Shea SM, Goldberg A, Liotta M, Potkul R, Winder A, Lee B, Jackson J, Roeske JC, Small W Jr, Harkenrider MM. Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer. Gynecol Oncol. 2024 Apr;183:33-38. doi: 10.1016/j.ygyno.2024.03.003. Epub 2024 Mar 15. PMID: 38492475. 
39. Siddiqui A, Ross D, Jani RH, Prabhu VC, Lo S, Wainwright DA, Rouse S, Refaat T, Zhu Y, Thakkar JP. Anti-aquaporin-4 immunoglobulin G/anti-myelin oligodendrocyte glycoprotein immunoglobulin G double-positive paraneoplastic neurological syndrome in a patient with triple-negative breast cancer. Clin Exp Neuroimmunol. 2024 Feb;15(1):55-60. doi: 10.1111/cen3.12767. Epub 2023 Sep 18. PMID: 38595690; PMCID: PMC11003753. 
40. Mortazavi SAR, Tahmasebi S, Lech JC, Welsh JS, Taleie A, Rezaianzadeh A, Zamani A, Mega K, Nematollahi S, Zamani A, Mortazavi SMJ, Sihver L. Digital Screen Time and the Risk of Female Breast Cancer: A Retrospective Matched Case- Control Study. J Biomed Phys Eng. 2024 Apr 1;14(2):169-182. doi:10.31661/jbpe.v0i0.2310-1678. PMID: 38628888; PMCID: PMC11016821. 
41. Rana Z, Kamran SC, Shetty AC, Sutera P, Song Y, Bazyar S, Solanki AA, Simko JP, Pollack A, McConkey D, Kates M, Siddiqui MM, Hiken J, Earls J, Messina D, Mouw KW, Miyamoto D, Shipley WU, Michaelson MD, Zietman A, Coen JJ, Dahl DM, Jani AB, Souhami L, Chang BK, Lee RJ, Pham H, Marshall DT, Shen X, Pugh SL, Feng FY, Efstathiou JA, Tran PT, Deek MP. Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712. Eur Urol Oncol. 2024 Apr 18:S2588-9311(24)00095-6. doi: 10.1016/j.euo.2024.03.015. Epub ahead of print. PMID: 38641541. 
42. Klopp AH, Enserro D, Powell M, Randall M, Schink JC, Mannel RS, Holman L, Bender D, Kushnir CL, Backes F, Zweizig SL, Waggoner S, Bradley KA, Lawrence LD, Hanjani P, Darus CJ, Small W Jr, Cardenes HR, Feddock JM, Miller DS. Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial. J Clin Oncol. 2024 Apr 25:JCO2301279. doi: 10.1200/JCO.23.01279. Epub ahead of print. PMID: 38662968. 
43. Anvari K, Seilanian Toussi M, Saghafi M, Javadinia SA, Saghafi H, Welsh JS. Extended dosing (12 cycles) vs conventional dosing (6 cycles) of adjuvant temozolomide in adults with newly diagnosed high-grade gliomas: a randomized, single-blind, two-arm, parallel-group controlled trial. Front Oncol. 2024 May 7;14:1357789. doi: 10.3389/fonc.2024.1357789. PMID: 38774410; PMCID: PMC11106464. 
44. Anker CJ, Tchelebi L, Selfridge JE, Jabbour SK, Akselrod D, Cataldo P, Abood G, Berlin J, Hallemeier CL, Jethwa KR, Kim E, Kennedy T, Lee P, Sharma N, Small W Jr, Williams VM, Russo S. Executive Summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC) for Non-Operative Management (NOM) for Rectal Adenocarcinoma: Systematic Review and Guidelines. Int J Radiat Oncol Biol Phys. 2024 May 24:S0360-3016(24)00673-4. doi: 10.1016/j.ijrobp.2024.05.019. Epub ahead of print. PMID: 38797496. 
45. Expert Panel on Breast Imaging; Niell BL, Jochelson MS, Amir T, Brown A, Adamson M, Baron P, Bennett DL, Chetlen A, Dayaratna S, Freer PE, Ivansco LK, Klein KA, Malak SF, Mehta TS, Moy L, Neal CH, Newell MS, Richman IB, Schonberg M, Small W Jr, Ulaner GA, Slanetz PJ. ACR Appropriateness Criteria® Female Breast Cancer Screening: 2023 Update. J Am Coll Radiol. 2024 Jun;21(6S):S126-S143. doi: 10.1016/j.jacr.2024.02.019. PMID: 38823941. 
46. Expert Panel on GYN and OB Imaging; Shinagare AB, Burk KS, Kilcoyne A, Akin EA, Chuang L, Hindman NM, Huang C, Rauch GM, Small W Jr, Stein EB, Venkatesan AM, Kang SK. ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Invasive Cancer of the Cervix: 2023 Update. J Am Coll Radiol. 2024 Jun;21(6S):S249-S267. doi: 10.1016/j.jacr.2024.02.026. PMID: 38823948. 
47. Welsh JS, Karam PA, Gale RP. Radiation exposure and space exploration. Leukemia. 2024 Jun 10. doi: 10.1038/s41375-024-02270-2. Epub ahead of print. PMID: 38858599.

Other CBCC-Affiliated Publications

1. Yang S, Bunn C, Kramer S, Thorpe E. The Dynamic Tracheoesophageal Prosthesis Length. J Voice. 2023 Jul;37(4):633.e1-633.e6. doi: 10.1016/j.jvoice.2021.03.025. Epub 2021 May 21. PMID: 34024697. 
2. Ryan CW, Tangen CM, Heath EI, Stein MN, Meng MV, Alva AS, Pal SK, Puzanov I, Clark JI, Choueiri TK, Agarwal N, Uzzo RG, Haas NB, Synold TW, Plets M, Vaishampayan UN, Shuch BM, Thompson IM Jr, Lara PN Jr. Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet. 2023 Sep 23;402(10407):1043-1051. doi: 10.1016/S0140-6736(23)00913-3. Epub 2023 Jul 28. PMID: 37524096; PMCID: PMC10622111. 
3. Verm RA, Baker MM, Cohn T, Park S, Swanson J, Freeman R, Abdelsattar ZM. Fragmented care, Commission on Cancer accreditation, and overall survival in patients receiving surgery and chemotherapy for esophageal cancer. Surgery. 2024 Mar;175(3):618-628. doi: 10.1016/j.surg.2023.07.026. Epub 2023 Sep 22. PMID: 37743107. 
4. Rao SM, Knott PD, Sweeny L, Domack A, Tang A, Patel R, Pittman AL, Gardner JR, Moreno MA, Sunde J, Cave TB, Knight ND, Greene B, Pipkorn P, Joshi AS, Thakkar P, Ji K, Yang S, Chang BA, Wax MK, Thomas CM. Microvascular Free Flap Outcomes in Maxillectomy Defects from Invasive Fungal Sinusitis. Laryngoscope. 2024 Apr;134(4):1642-1647. doi: 10.1002/lary.31081. Epub 2023 Sep 29. PMID: 37772913. 
5. Roat-Shumway S, Tonelli CM, Baker MS, Abdelsattar ZM. Prognosis of Unresected vs Resected Small Pulmonary Carcinoid Tumors. Ann Thorac Surg. 2023 Sep;116(3):553-561. doi: 10.1016/j.athoracsur.2023.04.008. Epub 2023 Apr 11. PMID: 37054928. 
6. Odeh AM, Perez-Tamayo RA, Abdelsattar ZM. A wedge is still better than stereotactic body radiation therapy in the national cancer database. J Thorac Cardiovasc Surg. 2024 Apr;167(4):e100-e101. doi: 10.1016/j.jtcvs.2023.08.044. Epub 2023 Sep 26. PMID: 37747399. 
7. Park SS, Verm RA, Abdelsattar ZM, Kramer S, Swanson J, Fernando M, Cohn T, Luchette FA, Baker MS. Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival? Surgery. 2024 Mar;175(3):695-703. doi: 10.1016/j.surg.2023.08.040. Epub 2023 Oct 18. PMID: 37863686. 
8. Domack A, Sandelski MM, Ali S, Blackwell KE, Buchakjian M, Bur AM, Cannady SB, Castellanos CX, Ducic Y, Ghanem TA, Huang AT, Jackson RS, Kokot N, Li S, Pipkorn P, Puram SV, Rezaee R, Rajasekaran K, Shnayder Y, Sinha UK, Sukato D, Suresh N, Tamaki A, Thomas CM, Thorpe EJ, Wax MK, Yang S, Ziegler A, Pittman AL. Free Flap Outcomes for Head and Neck Surgery in Patients with COVID-19. Laryngoscope. 2023 Nov 8. doi: 10.1002/lary.31159. Epub ahead of print. PMID: 37937733. 
9. Tedesco J, Nakahama H, Abdelsattar Z. Totally robotic en bloc left upper lobectomy and chest wall resection after neoadjuvant chemoradiation. Multimed Man Cardiothorac Surg. 2023 Nov 3;2023. doi: 10.1510/mmcts.2023.051. PMID: 37921749. 
10. Rojo M, Abdelsattar Z. Robotic resection of a second rib osteochondroma. Multimed Man Cardiothorac Surg. 2023 Nov 9;2023. doi: 10.1510/mmcts.2023.054. PMID: 37942805. 
11. Kyalwazi B, Yau C, Campbell MJ, Yoshimatsu TF, Chien AJ, Wallace AM, Forero-Torres A, Pusztai L, Ellis ED, Albain KS, Blaes AH, Haley BB, Boughey JC, Elias AD, Clark AS, Isaacs CJ, Nanda R, Han HS, Yung RL, Tripathy D, Edmiston KK, Viscusi RK, Northfelt DW, Khan QJ, Asare SM, Wilson A, Hirst GL, Lu R, Symmans WF, Yee D, DeMichele AM, van 't Veer LJ, Esserman LJ, Olopade OI. Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer. JAMA Netw Open. 2023 Dec 1;6(12):e2349646. doi: 10.1001/jamanetworkopen.2023.49646. PMID: 38153734; PMCID: PMC10755617. 
12. Bassetti MF, Morris BA, Sethakorn N, Lang JM, Schehr JL, Zhao SG, Morris ZS, Buehler D, Eickhoff JC, Harari PM, Traynor AM, Campbell TC, Baschnagel AM, Leal TA. Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase 1b Trial. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1481-1489. doi: 10.1016/j.ijrobp.2023.11.040. Epub 2023 Dec 8. PMID: 38072321; PMCID: PMC10947887. 
13. Ellis JL, Dalimov Z, Chew L, Quek ML. Preoperative optimization of the radical cystectomy patient: Current state and future directions. J Surg Oncol. 2024 Jan;129(1):138-144. doi: 10.1002/jso.27546. Epub 2023 Nov 30. PMID: 38037317. 
14. Kyalwazi B, Yau C, Campbell MJ, Yoshimatsu TF, Chien AJ, Wallace AM, Forero-Torres A, Pusztai L, Ellis ED, Albain KS, Blaes AH, Haley BB, Boughey JC, Elias AD, Clark AS, Isaacs CJ, Nanda R, Han HS, Yung RL, Tripathy D, Edmiston KK, Viscusi RK, Northfelt DW, Khan QJ, Asare SM, Wilson A, Hirst GL, Lu R, Symmans WF, Yee D, DeMichele AM, van 't Veer LJ, Esserman LJ, Olopade OI. Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer. JAMA Netw Open. 2023 Dec 1;6(12):e2349646. doi: 10.1001/jamanetworkopen.2023.49646. PMID: 38153734; PMCID: PMC10755617. 
15. Wang SY, Scurti GM, Dalheim AV, Quinn S, Stiff PJ, Nishimura MI. Nonactivated and IL-7 cultured CD19-specific CAR T cells are enriched in stem cell phenotypes and functionally superior. Blood Adv. 2024 Jan 23;8(2):324-335. doi: 10.1182/bloodadvances.2023010607. PMID: 37967375; PMCID: PMC10788799. 
16. Smith S, Lee Y, Borrowdale R, Thorpe E, Pittman A. Institutional experience with total pharyngectomy reconstruction: Exploring the role of the salivary bypass tube. Head Neck. 2024 Apr;46(4):721-727. doi: 10.1002/hed.27610. Epub 2024 Jan 2. PMID: 38165002. 
17. Albain KS, Yau C, Petricoin EF, Wolf DM, Lang JE, Chien AJ, Haddad T, Forero-Torres A, Wallace AM, Kaplan H, Pusztai L, Euhus D, Nanda R, Elias AD, Clark AS, Godellas C, Boughey JC, Isaacs C, Tripathy D, Lu J, Yung RL, Gallagher RI, Wulfkuhle JD, Brown-Swigart L, Krings G, Chen YY, Potter DA, Stringer-Reasor E, Blair S, Asare SM, Wilson A, Hirst GL, Singhrao R, Buxton M, Clennell JL, Sanil A, Berry S, Asare AL, Matthews JB, DeMichele AM, Hylton NM, Melisko M, Perlmutter J, Rugo HS, Symmans WF, Van't Veer LJ, Yee D, Berry DA, Esserman LJ. Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clin Cancer Res. 2024 Feb 16;30(4):729-740. doi: 10.1158/1078-0432.CCR-22-2256. PMID: 38109213; PMCID: PMC10956403. 
18. Bardia A, Pusztai L, Albain K, et al. TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy. Therapeutic Advances in Medical Oncology. 2024;16. doi:10.1177/17588359241248336 
19. Zraly CB, Schultz R, Diaz MO, Dingwall AK. New twists of a TAIL: novel insights into the histone binding properties of a highly conserved PHD finger cluster within the MLR family of H3K4 mono-methyltransferases. Nucleic Acids Res. 2023 Oct 13;51(18):9672-9689. doi: 10.1093/nar/gkad698. PMID: 37638761; PMCID: PMC10570056. 
20. Jethwa KR, Kim E, Berlin J, Anker CJ, Tchelebi L, Abood G, Hallemeier CL, Jabbour S, Kennedy T, Kumar R, Lee P, Sharma N, Small W Jr, Williams V, Russo S. Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma: Systematic Review and Guidelines. Am J Clin Oncol. 2024 Apr 1;47(4):185-199. doi: 10.1097/COC.0000000000001076. Epub 2023 Dec 22. PMID: 38131628. 
21. Hagen P, Norton J, Tsai S, Campo L, Lee M, Gomez K, Stiff P. Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma. Br J Haematol. 2024 Apr;204(4):1422-1428. doi: 10.1111/bjh.19281. Epub 2024 Jan 4. PMID: 38176404. 
22. Ross DH, Gomez K, Harmon G, Mysz ML, Shea SM, Goldberg A, Liotta M, Potkul R, Winder A, Lee B, Jackson J, Roeske JC, Small W Jr, Harkenrider MM. Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer. Gynecol Oncol. 2024 Apr;183:33-38. doi: 10.1016/j.ygyno.2024.03.003. Epub 2024 Mar 15. PMID: 38492475. 
23. Batchelor TT, Giri S, Ruppert AS, Geyer SM, Smith SE, Mohile N, Swinnen LJ, Friedberg JW, Kahl BS, Bartlett NL, Hsi ED, Cheson BD, Wagner-Johnston N, Nayak L, Leonard JP, Rubenstein JL. Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101. Blood Adv. 2024 Jun 25;8(12):3189-3199. doi: 10.1182/bloodadvances.2023011657. PMID: 38598710; PMCID: PMC11225669.